Table 1.
References | Character | Country | Size | Mean age (in years) | Allocation criteria | Participants | Surgical procedure details | Risk of bias |
---|---|---|---|---|---|---|---|---|
Bendifallah 2017 (13) | Retrospective cohort | France | Surgery: 55 ART: 55 |
Surgery: 31.3 ART: 32 |
Patients’ preferences | Women with infertility with DIE (in situ colorectal endometriosis) | Shaving, disc excision, or segmental resection | Low |
Bianchi 2009 (14) | Prospective cohort | Brazil | Surgery: 64 ART: 105 |
Surgery: 32 ART: 32 |
Patients’ preferences | Women with infertility with clinical and TVS diagnosis of DIE (with or without colorectal endometriosis) and <38 years | Extensive laparoscopic excision of all DIE lesions and endometriomas | High |
Ferrier 2023 (16) | Retrospective cohort | France | Surgery: 92 ART: 92 |
Surgery: 32.7 ART: 32 |
Patients’ preferences | Patients between 18 and 43 years with infertility associated with DIE without colorectal involvement |
Complete removal of endometriotic lesions by laparoscopy | High |
Maignien 2020 (12) | Retrospective cohort | France | Surgery: 155 ART: 67 |
All patients: 33 | Patients’ preferences | DE patients who underwent in vitro fertilization (IVF) or intra-cytoplasmic sperm injection (ICSI) treatment | NR | Moderate |
Mounsambote 2017 (17) | Retrospective cohort | France | Surgery: 35 ART: 37 |
Surgery: 32.1 ART: 33.1 |
Patients’ preferences | Women with infertility with DIE and without digestive involvement | Complete resection of endometriosis | High |
Rubod 2019 (15) | Retrospective cohort | France | Surgery: 78 ART: 64 |
All patients: 31.1 | Complete surgery: patients who were symptomatic. Incomplete surgery: asymptomatic patients only to facilitate IVF conditions. No surgery: asymptomatic patients with no affectation of IVF conditions |
Women with infertility with posterior deep endometriosis | Complete surgery of all DIE lesions and endometriomas after failure of medical treatment | High |
DIE, Deep infiltrating endometriosis; ART, Assisted Reproductive Technologies; TVS, Transvaginal sonography; IVF, In-vitro fertilization; NR, Not reported.